Moleculin Strengthens Board of Directors with Appointment of John M. Climaco
HOUSTON, TX--(Marketwired - July 27, 2017) - Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a preclinical pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based …